Synergic PDE3 and PDE4 control intracellular cAMP and cardiac excitation-contraction coupling in a porcine model
Delphine Mika(Inserm), Jérôme Leroy(Inserm), Amir Hodžić(Inserm), Catherine Rücker‐Martin(Inserm), Patrick Lechêne(Inserm), Jane‐Lise Samuel(Université Paris Cité), Vincent Algalarrondo(British Heart Foundation), Angèle Boët(Inserm), Malha Sadoune(Inserm), Grégoire Vandecasteele(Inserm), Rodolphe Fischmeister(Inserm), Virginie Lambert(Inserm), Marta Lindner(Université Paris-Sud), P Bobin(Universität Hamburg), Florence Lefebvre(Inserm)
Cited by 26
Related Papers
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
|New England Journal of Medicine|2024|410
Pulmonary embolism in COVID-19 patients: a French multicentre cohort study
|European Heart Journal|2020|263
Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
|Journal of Clinical Investigation|1996|233
Treatments targeting inotropy
|European Heart Journal|2018|227
Acutely Decompensated Heart Failure with Preserved and Reduced Ejection Fraction Present with Comparable Haemodynamic Congestion
|European Journal of Heart Failure|2017|160